Clinical trial Recruiting at 1 site Interventional Ages 40 to 75

How thinking affects relearning arm movements after stroke

Official title: The Role of Cognition in the Use of Enhanced Intrinsic Feedback for Motor Learning After Stroke

Run by McGill University · NCT05268861 · Data updated 2026-11-12

This project tests whether adding an error-augmentation feedback method helps people who had a recent stroke, especially those with thinking or memory problems, relearn upper-arm movements.

Quick facts

Study typeInterventional
Ages40 Years to 75 Years
SexAll
Enrollment24 (estimated)
SponsorMcGill University
Academic / other
Locations1 site (Laval, Quebec)
StatusRecruiting
StartedApril 1, 2022
Main results expectedJuly 2026
Study endsJuly 2026
Registry record updatedJune 4, 2025
Trial IDNCT05268861 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a first cortical or subcortical ischemic or hemorrhagic stroke less than three years ago who are medically stable, no longer receiving treatment, have arm paresis but can voluntarily flex/extend the elbow about 30 degrees, and have normal or corrected vision.

Probably not a fit

People with severe proprioceptive deficits, marked visuospatial neglect, major other neurological or musculoskeletal conditions, uncontrolled depression, or those unable to attend in-person sessions are unlikely to benefit or qualify.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with a first cortical or subcortical ischemic or hemorrhagic stroke within the past three years and residual arm weakness will be enrolled and classified for cognitive deficits. Participants will be randomized to motor training with either error augmentation (extra intrinsic feedback) or no additional feedback while performing upper-limb tasks. Motor learning will be measured by improvements during training and retention afterward to capture implicit learning. The study examines whether cognitive impairments limit use of feedback and whether error augmentation can improve learning despite those deficits.

Why it matters

Potential benefit: If successful, this approach could improve upper-limb recovery by identifying feedback strategies that boost motor learning for people with different cognitive profiles.

How similar studies have gone: Previous work using error augmentation and intrinsic feedback has shown promising motor-learning gains after stroke, but evidence on its effectiveness specifically in patients with cognitive deficits is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Sustained a first cortical/sub-cortical ischemic/hemorrhagic stroke less than 3 years previously and are medically stable.
* Are no longer receiving treatment.
* Normal or corrected-to-normal vision.
* Have arm paresis (Chedoke-McMaster Arm Scale 2-6/7) and spasticity (Modified Ashworth Scale ≥ 1/4) but can voluntarily flex/extend the elbow to approximately 30 degrees in each direction.

Exclusion Criteria:

* Other major neurological or musculoskeletal problems that may interfere with task performance.
* Marked elbow proprioceptive deficits (\<6/12 Fugl-Meyer UL sensation scale) that may interfere with elbow position perception.
* Visuospatial neglect (Line Bisection Test deviation \> 6 mm).
* Uncorrected vision.
* Depression (≥ 14 Beck Depression Inventory II).

Where it's running

  • Jewish Rehabilitation Hospital
    Laval, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.